Restriction of psoriatic skin and joint disease by A20
A20对银屑病皮肤和关节疾病的限制
基本信息
- 批准号:10343769
- 负责人:
- 金额:$ 18.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-05 至 2025-11-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalA20 proteinAdultAdvisory CommitteesAffectAnatomyAntigensArthritisAutomobile DrivingBindingBinding ProteinsBiologyCellsCellular ImmunologyChronic small plaque psoriasisComplexCutaneousCytokine Network PathwayDataDefectDevelopmentDevelopment PlansDiagnosisDigit structureDiseaseDistalEarly DiagnosisEducational workshopEpidermisEpithelialEvolutionFoundationsFunctional disorderGenesGenetic PolymorphismGenomicsGoalsHistologicHumanHuman CharacteristicsImmuneImmune signalingImmunologistImmunologyInflammationInflammatoryInflammatory InfiltrateInflammatory ResponseInterleukin-17JointsKnock-inKnowledgeLeadLeadershipLearningLightLinkLocationMentorsMentorshipModelingMolecularMouse StrainsMusNF-kappa BNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNaturePathogenesisPathogenicityPathologyPathway interactionsPatientsPhasePhysiciansPlayPopulationPositioning AttributePredispositionProcessProtein BiochemistryProteinsPsoriasisPsoriatic ArthritisPublishingResearchResearch PersonnelRheumatologyRoleScientistSeriesSignal PathwaySignal TransductionSignaling ProteinSkinStatistical Data InterpretationT-LymphocyteTNF geneTissuesTumor Necrosis Factor ReceptorTumor-infiltrating immune cellsUbiquitinUnited StatesVariantZinc Fingersarthropathiescareercareer developmentcytokineearly detection biomarkersexperimental studyfascinateimprovedin vivojoint destructionjoint inflammationkeratinocytekeratinocyte differentiationmouse modelmultidisciplinarymutantnew therapeutic targetnovelnovel therapeutic interventionnovel therapeuticspatient subsetspreventprogramsskillsskin disordersymposiumtherapeutic biomarkertranscriptomicstwo-dimensional
项目摘要
PROJECT SUMMARY: The relationship between psoriatic skin and joint disease remains enigmatic. A subset
of patients with psoriasis develop arthritis, early diagnosis of which is challenging. Additionally, therapies for
skin disease are less successful at treating arthritis. A20 (Tnfaip3) is a broadly-expressed protein that restricts
multiple inflammatory signaling pathways and is genetically associated with both psoriasis and psoriatic
arthritis in humans. However, the molecular and tissue-specific mechanisms by which A20 restricts psoriatic
disease are unknown. Our preliminary data shows that A20's capacity for binding linear ubiquitin is critical for
preventing distal digit psoriatic skin and joint disease in mice, with pathology requiring TNF, IL17A, and T-cells.
Early disease surrounded the epidermis; therefore, we generated mice allowing inducible deletion of A20 only
in keratinocytes in adulthood (A20iEKO mice). Remarkably, these mice also develop similar psoriatic skin and
joint disease that requires TNF, IL17A, and T-cells. I aim to determine the immune mechanisms by which A20
dysregulation in keratinocytes orchestrates skin and joint disease. Aim 1 centers around understanding the
cytokine requirements for coordinating the pathogenic immune infiltrate. In Aim 2 I will dissect the role of T-
cells by determining which subsets or antigen-specific cells are critical for pathogenic cytokine secretion as
well as their anatomical sites of action. Aim 3 focuses on the cell-intrinsic role of A20 in keratinocytes, where I
plan to understand the mechanisms by which A20 restricts inflammatory pathways in vivo, during keratinocyte
differentiation, and downstream TNFR and IL17R. Together, these studies will reveal how keratinocytes can
orchestrate an inflammatory process that results in psoriatic skin and joint disease. This is relevant to NIAMS
because these studies may help explain how human psoriasis is connected to psoriatic arthritis and may reveal
novel therapeutic targets or biomarkers for early or potential arthritic disease.
My long-term goal is to establish an independent research program studying how inflammation remains
localized within epithelial tissues such as the skin. The studies described above will provide an outstanding
starting point as they aim to understand how skin dysregulation can cause joint inflammation. My research
background is primarily in cellular signaling and protein biochemistry. My career development aims are to build
my intellectual and scientific foundation in cellular immunology and develop professional relationships with
rheumatology-focused researchers. I also plan on developing key research skills in epithelial biology as well as
transcriptomic and statistical analysis. These development goals will be pursued with didactic courses along
with participation in seminar series, workshops, and conferences. Together with mentorship from Dr. Averil Ma,
a leading molecular immunologist, and guidance from a multidisciplinary scientific advisory committee of
immunologists, epithelial biologists, and genomics experts, these aims will position me for an independent
research career as a physician-scientist.
项目摘要:银屑病皮肤与关节疾病之间的关系仍然是个谜。一个子集
的牛皮癣患者会出现关节炎,其早期诊断具有挑战性。此外,治疗
皮肤病在治疗关节炎方面不太成功。 A20 (Tnfaip3) 是一种广泛表达的蛋白质,限制
多种炎症信号传导途径,并且与银屑病和银屑病有遗传相关性
人类关节炎。然而,A20 限制银屑病的分子和组织特异性机制
疾病未知。我们的初步数据表明,A20 结合线性泛素的能力对于
预防小鼠远端手指银屑病皮肤和关节疾病,其病理学需要 TNF、IL17A 和 T 细胞。
早期疾病围绕表皮;因此,我们培育了仅允许诱导性缺失 A20 的小鼠
成年期角质形成细胞(A20iEKO 小鼠)。值得注意的是,这些小鼠也出现类似的银屑病皮肤和
需要 TNF、IL17A 和 T 细胞的关节疾病。我的目标是确定 A20 的免疫机制
角质形成细胞的失调会导致皮肤和关节疾病。目标 1 围绕理解
协调致病性免疫浸润的细胞因子需求。在目标 2 中我将剖析 T 的角色-
通过确定哪些亚群或抗原特异性细胞对于致病性细胞因子分泌至关重要,
以及它们的作用解剖部位。目标 3 重点关注 A20 在角质形成细胞中的细胞内在作用,其中我
计划了解 A20 在角质形成细胞过程中限制体内炎症途径的机制
分化,以及下游 TNFR 和 IL17R。这些研究将共同揭示角质形成细胞如何
精心策划导致银屑病皮肤和关节疾病的炎症过程。这与 NIAMS 相关
因为这些研究可能有助于解释人类牛皮癣与牛皮癣关节炎之间的关系,并可能揭示
早期或潜在关节炎疾病的新治疗靶点或生物标志物。
我的长期目标是建立一个独立的研究项目,研究炎症如何持续存在
位于上皮组织内,例如皮肤。上述研究将提供出色的
他们的目的是了解皮肤失调如何导致关节炎症。我的研究
背景主要是细胞信号传导和蛋白质生物化学。我的职业发展目标是建立
我在细胞免疫学方面的知识和科学基础,并与
以风湿病学为重点的研究人员。我还计划发展上皮生物学以及
转录组和统计分析。这些发展目标将通过教学课程来实现
参加系列研讨会、讲习班和会议。在Averil Ma博士的指导下,
领先的分子免疫学家,以及多学科科学咨询委员会的指导
免疫学家、上皮生物学家和基因组学专家,这些目标将使我成为一个独立的
作为一名医师科学家的研究生涯。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bahram Razani其他文献
Bahram Razani的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bahram Razani', 18)}}的其他基金
Role of antiviral signaling in psoriatic pathogenesis
抗病毒信号在银屑病发病机制中的作用
- 批准号:
10643178 - 财政年份:2023
- 资助金额:
$ 18.9万 - 项目类别:
Restriction of psoriatic skin and joint disease by A20
A20对银屑病皮肤和关节疾病的限制
- 批准号:
10536649 - 财政年份:2021
- 资助金额:
$ 18.9万 - 项目类别:
相似国自然基金
A20通过增加STC1表达阻断钙网蛋白膜转位,促进肠癌免疫逃逸的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TAX1BP1/锌指蛋白A20协同抑制TLR2-NF-κB活化诱导内皮细胞免疫耐受治疗AS的研究
- 批准号:82000339
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
增加锌指蛋白A20表达对糖尿病心肌病心肌重构的影响及其作用机制
- 批准号:
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
锌指蛋白A20负调控宫内生长迟缓致成年期哮喘的作用机制
- 批准号:81871220
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
A20在巨噬细胞调节肺纤维化发病中的作用和机制
- 批准号:81803604
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of antiviral signaling in psoriatic pathogenesis
抗病毒信号在银屑病发病机制中的作用
- 批准号:
10643178 - 财政年份:2023
- 资助金额:
$ 18.9万 - 项目类别:
Restriction of psoriatic skin and joint disease by A20
A20对银屑病皮肤和关节疾病的限制
- 批准号:
10536649 - 财政年份:2021
- 资助金额:
$ 18.9万 - 项目类别:
Improved liver function and regeneration with A20
A20 改善肝功能和再生
- 批准号:
8281669 - 财政年份:2003
- 资助金额:
$ 18.9万 - 项目类别: